Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Top Cited Papers
- 26 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Microbiology
- Vol. 5 (12), 1598-1607
- https://doi.org/10.1038/s41564-020-00813-8
Abstract
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-2 in the human population, it is not known how long antibody responses will be maintained or whether they will provide protection from reinfection. Using sequential serum samples collected up to 94 d post onset of symptoms (POS) from 65 individuals with real-time quantitative PCR-confirmed SARS-CoV-2 infection, we show seroconversion (immunoglobulin (Ig)M, IgA, IgG) in >95% of cases and neutralizing antibody responses when sampled beyond 8 d POS. We show that the kinetics of the neutralizing antibody response is typical of an acute viral infection, with declining neutralizing antibody titres observed after an initial peak, and that the magnitude of this peak is dependent on disease severity. Although some individuals with high peak infective dose (ID50 > 10,000) maintained neutralizing antibody titres >1,000 at >60 d POS, some with lower peak ID50 had neutralizing antibody titres approaching baseline within the follow-up period. A similar decline in neutralizing antibody titres was observed in a cohort of 31 seropositive healthcare workers. The present study has important implications when considering widespread serological testing and antibody protection against reinfection with SARS-CoV-2, and may suggest that vaccine boosters are required to provide long-lasting protection.Keywords
Funding Information
- RCUK | Medical Research Council (MC/PC/15068, MR/N013700/1, MR/R015643/1, MR/N013700/1, MC/PC/15068, MR/R015643/1, MR/S023747/1, MC/PC/15068)
- Huo Family Foundation
- Wellcome Trust (WT098049AIA, MR/S023747/1, 106223/Z/14/Z, 106223/Z/14/Z, 106223/Z/14/Z)
- Huo Family Foundation King’s Together Rapid COVID-19 Call award
- DH | National Institute for Health Research (CS-2016-16-011)
- King’s Together Rapid COVID-19 Call award Huo Family Foundation
- Fondation Dormeur, Vaduz King’s Together Rapid COVID-19 Call award Huo Family Foundation
This publication has 62 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnessesJournal of Medical Virology, 2020
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- An optimised method for the production of MERS-CoV spike expressing viral pseudotypesMethodsX, 2015
- Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in ChinaPLOS ONE, 2011
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensThe New England Journal of Medicine, 2007
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryThe New England Journal of Medicine, 2007
- Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndromeJournal of Clinical Virology, 2006
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990